Arnaud C. Verschuur

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Establishing a national multidisciplinary board for complex pediatric renal tumors: Lessons learned.

Establishing a national multidisciplinary board for complex pediatric renal tumors: Lessons learned.

Journal: Bulletin du cancer

Published: January 30, 2025

Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG).

Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG).

Journal: British journal of cancer

Published: March 04, 2024

Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial.

Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 25, 2023

Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93-01, 2001 and UK-IMPORT database: A report of the SIOP-Renal Tumor Study Group.

Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93-01, 2001 and UK-IMPORT database: A report of the SIOP-Renal Tumor Study Group.

Journal: International journal of cancer

Published: August 12, 2020

Standard of care for adult Wilms tumor? From adult urologist to pediatric oncologist. A retrospective review.

Standard of care for adult Wilms tumor? From adult urologist to pediatric oncologist. A retrospective review.

Journal: Bulletin du cancer

Published: May 26, 2020

Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab-irinotecan in children with low-grade glioma?

Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab-irinotecan in children with low-grade glioma?

Journal: Cancer medicine

Published: December 04, 2015

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study.

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 05, 2013

CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations.

CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations.

Journal: Pharmacogenomics

Published: March 03, 2012

Reirradiation and concomitant metronomic temozolomide: an efficient combination for local control in medulloblastoma disease?

Reirradiation and concomitant metronomic temozolomide: an efficient combination for local control in medulloblastoma disease?

Journal: Journal of pediatric hematology/oncology

Published: November 02, 2011

Showing 1-9 of 9

Last Updated: 09/26/2026